Health ❯Healthcare ❯Drug Approval

FDA

ARS Pharmaceuticals Clinical Trials AstraZeneca Regulatory Decisions Cobenfy Efficacy and Safety Eli Lilly Suzetrigine Public Health Lenacapavir Approval GSK New Drug Class Medical Devices Novavax Kisqali

4 ARTICLES

last wk.

FDA Demands New Trials for Novavax COVID Vaccine, Raising Concerns Over Fall Booster Rollouts

The FDA's decision to require fresh clinical trials for updated COVID-19 vaccines marks a departure from prior practices and could delay timely booster availability for vulnerable populations.

4 ARTICLES

last mo.

FDA Approves Neffy, the First Needle-Free Epinephrine Nasal Spray for Anaphylaxis

11 ARTICLES

9mo ago

FDA Approves Neffy: First Needle-Free Epinephrine Nasal Spray for Allergic Reactions

FDA

FDA Demands New Trials for Novavax COVID Vaccine, Raising Concerns Over Fall Booster Rollouts

FDA Approves First New Oral Antibiotic for UTIs in Nearly 30 Years

FDA Approves First New Oral Antibiotic for UTIs in Over 20 Years

FDA Approves Journavx, First Non-Opioid Painkiller in Over 20 Years

Bristol Myers Squibb Surpasses Q3 Expectations, Raises 2024 Outlook

FDA Approves Regeneron-Sanofi's Dupixent for COPD Treatment

FDA Approves First At-Home Nasal Spray Flu Vaccine

FDA Expands Approval of Kisqali for Early-Stage Breast Cancer

FDA Approves Neffy, the First Needle-Free Epinephrine Nasal Spray for Anaphylaxis

FDA Approves Neffy: First Needle-Free Epinephrine Nasal Spray for Allergic Reactions